NCT01141088

Brief Summary

The overall median survival of nonresectable malignant hilar obstruction in most series has been less than 6 months. Most patients with malignant hilar obstruction present with advanced disease, making allative endoscopic drainage the principal therapeutic option. However, the optimal endoscopic management strategy is contentious. In malignant hilar obstruction, exclusively endoscopic placement of bilateral metal stents has been considered very difficult and complex, and it may require multiple procedures, with an increased risk of complications and mortality. To overcome this difficulty and strategize plan of management, the investigators evaluated the technical and clinical efficacy of endoscopic bilateral placement of newly designed stents, Y-configuration, followed by side-by-side insertion in failure of stent-in-stent method for the management of malignant hilar obstruction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2016

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 10, 2010

Completed
5.8 years until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2018

Completed
Last Updated

December 19, 2017

Status Verified

December 1, 2017

Enrollment Period

2 years

First QC Date

June 8, 2010

Last Update Submit

December 15, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Technical success

    Passage of the double stent across the stricture,along with flow of contrast medium and/or bile through the stent. Adequate expansion: 70% of maximal expanded diameter was dilated within 24 hr.

    within 24 hr

Secondary Outcomes (4)

  • Early complications

    within 30 days after stent insertion

  • Late complications

    after 30 days following stent insertion

  • Median stent patency

    up to 1 year, from stent insertion to the occlusion of the stent

  • Median survival

    1 year, from stent insertion to the death of the patient

Study Arms (2)

Bilateral stent-in-stent insertion

EXPERIMENTAL

The passage of the bilateral metal stent across the stricture, stent-in-stent method.

Procedure: Bilateral stent-in-stent insertionProcedure: Bilateral side-by-side insertion

Bilateral side-by-side insertion

ACTIVE COMPARATOR

The passage of the bilateral metal stent across the stricture, side-by-side method.

Procedure: Bilateral stent-in-stent insertionProcedure: Bilateral side-by-side insertion

Interventions

Following negotiation of both IHD by two guidewires, inserted 1st stent to left IHD side. After deployment of the 1st stent across the hilar stricture, the remaining guide wire across the 1st stent was carefully withdrawn using an ERCP catheter without pulling it back completely. Then that guidewie was inserted under fluoroscopic guidance into the undrained right IHD through the central portion of the 1st stent. The 2nd cross-wired stent was then introduced over a guidewire through the central open mesh and then was deployed into the right IHD, so that the central portion of the 2nd stent overlapped the central portion of the 1st stent, forming a Y-shape.

Also known as: SIS
Bilateral side-by-side insertionBilateral stent-in-stent insertion

Following the introduction of two guidewires, the first stent was pushed and deployed into the left hepatic duct as possible, and then subsequently the second stent was pushed and deployed into the right hepatic duct, using the same method. In tight stricture during a guidewire manipulation, pneumatic biliary balloon dilation prior to insertion of first stent was performed. All stents were positioned above the level of the papilla, with their distal ends at the same level as possible. The diameter of the stent used in each case (8 or 10 mm) depended on the maximum diameter of the common bile duct (CBD).

Also known as: SBS
Bilateral side-by-side insertionBilateral stent-in-stent insertion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient over 18 years old
  • patient with malignant hilar obstruction

You may not qualify if:

  • refuse to participate in this study
  • refuse to provide informed consent
  • Karnofsky score \< 60%
  • physically unfit for endoscopic procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Soon Chun Hyang University College of Medicine, Bucheon Hospital

Bucheon-si, 420-767, South Korea

RECRUITING

Soon Chun Hyang University College of Medicine, Cheonan Hospital

Cheonan, 330-721, South Korea

RECRUITING

Related Publications (1)

  • Lee TH, Moon JH, Choi JH, Lee SH, Lee YN, Paik WH, Jang DK, Cho BW, Yang JK, Hwangbo Y, Park SH. Prospective comparison of endoscopic bilateral stent-in-stent versus stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture. Gastrointest Endosc. 2019 Aug;90(2):222-230. doi: 10.1016/j.gie.2019.03.011. Epub 2019 Mar 21.

Study Officials

  • Jong Ho Moon, MD, PhD

    Soon Chun Hyang University College of Medicine, Bucheon Hospital, Bucheon, South Korea

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jong Ho Moon, MD, PhD

CONTACT

Tae Hoon Lee, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

June 8, 2010

First Posted

June 10, 2010

Study Start

April 1, 2016

Primary Completion

March 30, 2018

Study Completion

September 30, 2018

Last Updated

December 19, 2017

Record last verified: 2017-12

Data Sharing

IPD Sharing
Will not share

Locations